Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TLX.AX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Telix Pharmaceuticals Limited stock price ended at $15.35 on Thursday, after gaining 0.458%.
(Updated on May 09, 2024)

Buy or Hold candidate since Mar 14, 2024 Gain 33.02% PDF

The Telix Pharmaceuticals Limited stock price gained 0.458% on the last trading day (Thursday, 9th May 2024), rising from $15.28 to $15.35. During the last trading day the stock fluctuated 2.59% from a day low at $15.03 to a day high of $15.42. The price has risen in 6 of the last 10 days and is up by 3.16% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 149 thousand more shares were traded than the day before. In total, 883 thousand shares were bought and sold for approximately $13.55 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 34.80% during the next 3 months and, with a 90% probability hold a price between $18.30 and $21.65 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TLX.AX Signals & Forecast

The Telix Pharmaceuticals Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $15.05 and $13.53. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, April 29, 2024, and so far it has fallen -1.03%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Telix Pharmaceuticals Limited stock

Telix Pharmaceuticals Limited finds support from accumulated volume at $15.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.390 between high and low, or 2.59%. For the last week, the stock has had daily average volatility of 3.40%.

Our recommended stop-loss: $14.76 (-3.85%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (TLX.AX) For The Upcoming Trading Day Of Friday 10th

For the upcoming trading day on Friday, 10th we expect Telix Pharmaceuticals Limited to open at $15.27, and during the day (based on 14 day Average True Range), to move between $14.81 and $15.89, which gives a possible trading interval of +/-$0.541 (+/-3.52%) up or down from last closing price. If Telix Pharmaceuticals Limited takes out the full calculated possible swing range there will be an estimated 7.05% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $15.51 (1.04%) than the support at $15.05 (1.95%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Telix Pharmaceuticals Limited stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Telix Pharmaceuticals Limited stock to perform well in the short-term.

Current score: 2.194 Buy Candidate Unchanged

Predicted Opening Price for Telix Pharmaceuticals Limited of Friday, May 10, 2024

Fair opening price May 10, 2024 Current price
$15.27 ( 0.543%) $15.35

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TLX.AX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 15.66 2.00 %
R2 15.51 1.03 %
R1 15.42 0.428 %
Current price: 15.35
Support S1 15.12 -1.51 %
S2 15.03 -2.11 %
S3 14.88 -3.08 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 15.51 1.04 %
Current price 15.35
Support S1 15.05 -1.95%
S2 13.72 -10.62%
S3 12.08 -21.30%

FAQ

What is the symbol for Telix Pharmaceuticals Limited Stock and on which exchange is it traded?
The symbol for Telix Pharmaceuticals Limited is TLX.AX and it is traded on the ASX (Australian Securities Exchange).

Should I buy or sell Telix Pharmaceuticals Limited Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Telix Pharmaceuticals Limited stock to perform well in the short-term.

How to buy Telix Pharmaceuticals Limited Stock?
Telix Pharmaceuticals Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Telix Pharmaceuticals Limited Stock.

What's the current price of Telix Pharmaceuticals Limited Stock?
As of the end of day on the May 09, 2024, the price of an Telix Pharmaceuticals Limited (TLX.AX) share was $15.35.

What is the 52-week high and low for Telix Pharmaceuticals Limited Stock?
The 52-week high for Telix Pharmaceuticals Limited Stock is $15.57 and the 52-week low is $8.20.

What is the market capitalization of Telix Pharmaceuticals Limited Stock?
As of the May 09, 2024, the market capitalization of Telix Pharmaceuticals Limited is 5.049B.

When is the next earnings date for Telix Pharmaceuticals Limited?
The upcoming earnings date for Telix Pharmaceuticals Limited is Aug 22, 2024.
Click to get the best stock tips daily for free!

About Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited Telix Pharmaceuticals Limited, a radiopharmaceutical company, develops molecularly targeted radiation (MTR) products for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company focuses on developing diagnostic and therapeutic products using MTR. Its lead products include TLX591-CDx for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX66-CDx to treat bone marrow conditi... TLX.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT